Advertisement

Variable Proton Relative Biological Effectiveness: How Do We Move Forward?

  • Tracy Underwood
    Affiliations
    Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts

    Department of Medical Physics and Bioengineering, University College London, London, United Kingdom
    Search for articles by this author
  • Harald Paganetti
    Correspondence
    Reprint requests to: Harald Paganetti, PhD, Department of Radiation Oncology, Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114. Tel: (617) 726 5847
    Affiliations
    Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
    Search for articles by this author
      In photon radiation therapy, dose prescriptions have been refined over decades of clinical practice to obtain a balance between tumor control and normal tissue damage. Drawing upon this experience, these prescriptions are used as the basis for proton therapy. Historically they have been reduced by a factor of 1.1: a fixed relative biological effectiveness (RBE). Relative biological effectiveness is defined as the ratio of doses required by two radiations to cause the same level of biological effect. The notion that a single scaling factor may be used to equate the effects of two radiations across all biological endpoints and doses is clearly naïve, yet thus far clinical proton therapy has adopted this simplistic approach.
      To read this article in full you will need to make a payment
      ASTRO Member Login
      ASTRO Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features.

      Purchase one-time access:

      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Paganetti H.
        Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer.
        Phys Med Biol. 2014; 59: R419-R472
        • Sethi R.
        • Giantsoudi D.
        • Raiford M.
        • et al.
        Patterns of failure following proton therapy in medulloblastoma: LET distributions and RBE associations for relapses.
        Int J Radiat Oncol Biol Phys. 2014; 90: S720
        • Giantsoudi D.
        • Sethi R.
        • Yeap B.Y.
        • et al.
        Incidence of CNS injury for a cohort of 111 patients treated with proton therapy for medulloblastoma; LET and RBE associations for areas of injury.
        Int J Radiat Oncol Biol Phys. 2015; 95: 276-285
        • Guan F.
        • Bronk L.
        • Titt U.
        • et al.
        Spatial mapping of the biologic effectiveness of scanned particle beams: Towards biologically optimized particle therapy.
        Sci Rep. 2015; 5: 9850
        • Buchsbaum J.C.
        • McDonald M.W.
        • Johnstone P.A.
        • et al.
        Range modulation in proton therapy planning: A simple method for mitigating effects of increased relative biological effectiveness at the end-of-range of clinical proton beams.
        Radiat Oncol. 2014; 9: 1-10
        • Kanai T.
        • Endo M.
        • Minohara S.
        • et al.
        Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapy.
        Int J Radiat Oncol Biol Phys. 1999; 44: 201-210
        • Unkelbach J.
        • Chan T.C.
        • Bortfeld T.
        Accounting for range uncertainties in the optimization of intensity modulated proton therapy.
        Phys Med Biol. 2007; 52: 2755-2773
        • Grassberger C.
        • Trofimov A.
        • Lomax A.
        • et al.
        Variations in linear energy transfer within clinical proton therapy fields and the potential for biological treatment planning.
        Int J Radiat Oncol Biol Phys. 2011; 80: 1559-1566
        • Wedenberg M.
        • Toma-Dasu I.
        Disregarding RBE variation in treatment plan comparison may lead to bias in favor of proton plans.
        Med Phys. 2014; 41: 091706
        • Cometto A.
        • Russo G.
        • Bourhaleb F.
        • et al.
        Direct evaluation of radiobiological parameters from clinical data in the case of ion beam therapy: An alternative approach to the relative biological effectiveness.
        Phys Med Biol. 2014; 59: 7393-7417
        • Skripcak T.
        • Belka C.
        • Bosch W.
        • et al.
        Creating a data exchange strategy for radiotherapy research: Towards federated databases and anonymised public datasets.
        Radiother Oncol. 2014; 113: 303-309
        • Liu Q.
        • Ghosh P.
        • Magpayo N.
        • et al.
        Lung cancer cell line screen links Fanconi anemia pathway defects to increased relative biological effectiveness of proton radiation.
        Int J Radiat Oncol Biol Phys. 2015; 91: 1081-1089
        • Grosse N.
        • Fontana A.O.
        • Hug E.B.
        • et al.
        Deficiency in homologous recombination renders mammalian cells more sensitive to proton versus photon irradiation.
        Int J Radiat Oncol Biol Phys. 2014; 88: 175-181
        • Gensheimer M.F.
        • Yock T.I.
        • Liebsch N.J.
        • et al.
        In vivo proton beam range verification using spine MRI changes.
        Int J Radiat Oncol Biol Phys. 2010; 78: 268-275
        • Hamdi D.H.
        • Barbieri S.
        • Chevalier F.
        • et al.
        In vitro engineering of human 3D chondrosarcoma: A preclinical model relevant for investigations of radiation quality impact.
        BMC Cancer. 2015; 15: 579
        • McNamara A.L.
        • Schuemann J.
        • Paganetti H.
        A phenomenological relative biological effectiveness (RBE) model for proton therapy based on all published in vitro cell survival data.
        Phys Med Biol. 2015; 60: 8399-8416
        • Wedenberg M.
        • Lind B.K.
        • Hårdemark B.
        A model for the relative biological effectiveness of protons: The tissue specific parameter α/β of photons is a predictor for the sensitivity to LET changes.
        Acta Oncol. 2013; 52: 580-588
        • Carabe A.
        • Moteabbed M.
        • Depauw N.
        • et al.
        Range uncertainty in proton therapy due to variable biological effectiveness.
        Phys Med Biol. 2012; 57: 1159

      Comments

      Commenting Guidelines

      To submit a comment for a journal article, please use the space above and note the following:

      • We will review submitted comments as soon as possible, striving for within two business days.
      • This forum is intended for constructive dialogue. Comments that are commercial or promotional in nature, pertain to specific medical cases, are not relevant to the article for which they have been submitted, or are otherwise inappropriate will not be posted.
      • We require that commenters identify themselves with names and affiliations.
      • Comments must be in compliance with our Terms & Conditions.
      • Comments are not peer-reviewed.